Sign In
Get Clay Free →

Suggestions

    Roger Lane MD, MPH

    Senior Vice President Neurology Clinical Development at Ionis Pharmaceuticals, Inc.

    Professional Background

    Dr. Roger Lane, MD, MPH, is a distinguished figure in the field of neurology and neuromuscular disorders, recognized for his dedication to developing disease-modifying treatments for patients affected by debilitating neurological diseases. With an extensive career spanning over three decades, Dr. Lane has held prominent positions in both clinical development and medical affairs across various leading pharmaceutical companies. His profound understanding of the complexities of drug development, particularly in neurological and psychiatric domains, has made him a sought-after leader in the industry.

    Dr. Lane began his career in pediatrics and general medicine after earning his Medical Doctorate from the University of Bristol in 1984. He transitioned into the pharmaceutical sector in 1989 when he joined Roche UK, initiating his journey in early clinical development. Following this, he significantly impacted global clinical development at Pfizer in New York, where he successfully led efforts surrounding the commercialization of Zoloft, a pioneering treatment for depression and anxiety disorders.

    Later, at Novartis, he served as the Disease Area Section Head for Dementia in Clinical Development and Medical Affairs, where his visionary leadership led to the ideation and development of Exelon capsules for Parkinson's disease dementia and the Exelon transdermal patch for Alzheimer’s disease. These innovative treatments have opened new avenues for managing these complex conditions and significantly improved patients' living conditions.

    Dr. Lane's career progressed as he became the Development and Medical Affairs Lead at Bristol-Myers Squibb (BMS), where he focused on a series of triple monoamine reuptake inhibitors, ultimately enhancing options for patients struggling with mood disorders and neurodegenerative diseases. Currently, he is recognized as the Head of Neurology Clinical Development at Ionis Pharmaceuticals, where he strategizes, designs, and executes clinical trials for drug candidates targeting common, rare, and ultra-rare neurological disorders. His commitment to improving clinical outcomes for patients with neurological challenges shines through his work and leadership.

    Education and Achievements

    Roger Lane's educational foundation is rooted in a strong commitment to public health and medicine. He obtained his Master of Public Health (MPH) from Columbia University in New York in 1998, which equipped him with strategic insights into public health policies and practices essential for advancing healthcare initiatives. His earlier studies in Medicine culminated in an MD from the University of Bristol in the UK in 1984. Further enhancing his early education, he attended King's School in Worcester, which laid the groundwork for his pursuit of excellence in medicine.

    Throughout his career, Dr. Lane has authored over 90 peer-reviewed publications, encompassing a wealth of knowledge that has enriched the scientific community and contributed to transformative insights in neurology. His 28 review articles highlight his capacity to synthesize and communicate complex information effectively. Furthermore, he holds three patents, demonstrating his innovative approach and ability to translate groundbreaking scientific discoveries into tangible medical solutions.

    Achievements

    Dr. Roger Lane's career features numerous accomplishments that underline his expertise and commitment to the field of neurology. As the former Senior Vice President and Head of Neurology Clinical Development at Ionis Pharmaceuticals, he played a pivotal role in advancing the neuroscience pipeline, spearheading significant clinical trial programs that address unmet medical needs. His leadership capabilities were instrumental in fostering an environment of innovation, resulting in high-performing teams dedicated to developing novel treatments.

    In his previous position as Vice President at Ionis, Dr. Lane cemented his reputation as a thought leader in the industry, guiding the clinical development of groundbreaking therapies in neurology. His tenure at Bristol-Myers Squibb and Novartis further established him as a major influencer in the field, with achievements such as overseeing the launch and development of key products that have made substantial impacts on patient care in neurology.

    In addition, Dr. Lane’s collaborative spirit and dedication to mentoring emerging professionals in the field are noteworthy, with many of his mentees progressing to senior leadership roles under his guidance. His holistic approach to leadership emphasizes the importance of integrating diverse information, strategic thinking, and innovative problem-solving skills to address complex challenges effectively.

    Looking Ahead

    With a passion for transforming the landscape of neurology and improving treatment options for patients and their families, Dr. Roger Lane aims to leverage his extensive experience and knowledge to make a significant difference. His unwavering commitment to understanding disease mechanisms and improving treatment pathways for neurological disorders remains at the forefront of his career aspirations, ensuring that he continues to contribute meaningfully to the field and to patients in need.

    titles/roles

    clinical development

    medical affairs

    neurology

    neurodegeneration

    mood disorders

    public health

    drug safety

    medical director

    executive leadership

    clinical research

    team management

    Related Questions

    How did Roger Lane develop his passion for neurology and medical research?
    What strategies has Roger Lane employed to lead high-performing teams in drug development?
    How did Roger Lane's education at Bristol University Medical School and Columbia University influence his career path?
    What innovative treatments has Roger Lane contributed to during his tenure in pharmaceutical companies?
    How does Roger Lane see the future of disease-modifying treatments in neurology?
    R
    Add to my network

    Location

    Carlsbad, California, United States